Kewaunee Scientific to Report Results for First Quarter Fiscal Year 2025
Rhea-AI Summary
Kewaunee Scientific (NASDAQ: KEQU) has announced plans to release its first quarter fiscal year 2025 financial results on Wednesday, September 11, 2024, after the close of trading. The information will be available on the company's website following the release.
Kewaunee Scientific, founded in 1906, is a global leader in designing, manufacturing, and installing laboratory, healthcare, and technical furniture products. The company's product range includes steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
Headquartered in Statesville, North Carolina, Kewaunee Scientific has sales offices in the United States, India, Saudi Arabia, and Singapore. It operates three manufacturing facilities in Statesville and one in Bangalore, India, serving domestic and international markets.
Positive
- Scheduled release of Q1 FY2025 financial results, indicating transparency and regular reporting
- Global presence with sales offices in multiple countries
- Diversified product portfolio in laboratory, healthcare, and technical furniture sectors
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, KEQU declined 2.25%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
About Kewaunee Scientific
Founded in 1906, Kewaunee Scientific Corporation is a recognized global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. The Company's products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
The Company's corporate headquarters are located in
This press release contains statements that the Company believes to be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact included in this press release, including statements regarding the Company's future financial condition, results of operations, business operations and business prospects, are forward-looking statements. Words such as "anticipate," "estimate," "expect," "project," "intend," "plan," "predict," "believe" and similar words, expressions and variations of these words and expressions are intended to identify forward-looking statements. Such forward-looking statements are subject to known and unknown risks, uncertainties, assumptions, and other important factors that could significantly impact results or achievements expressed or implied by such forward-looking statements. Such factors, risks, uncertainties and assumptions include, but are not limited to: competitive and general economic conditions, including disruptions from government mandates, both domestically and internationally, as well as supplier constraints and other supply disruptions; changes in customer demands; technological changes in our operations or in our industry; dependence on customers' required delivery schedules; risks related to fluctuations in the Company's operating results from quarter to quarter; risks related to international operations, including foreign currency fluctuations; changes in the legal and regulatory environment; changes in raw materials and commodity costs; acts of terrorism, war, governmental action, and natural disasters and other Force Majeure events. The cautionary statements made pursuant to the Reform Act herein and elsewhere by us should not be construed as exhaustive. We cannot always predict what factors would cause actual results to differ materially from those indicated by the forward-looking statements. Over time, our actual results, performance, or achievements will likely differ from the anticipated results, performance or achievements that are expressed or implied by our forward-looking statements, and such difference might be significant and harmful to our stockholders' interest. Many important factors that could cause such a difference are described under the caption "Risk Factors," in Item 1A of our Annual Report on Form 10-K for the fiscal year ended April 30, 2024, which you should review carefully, and in our subsequent quarterly reports on Form 10-Q and current reports on Form 8-K. These reports are available on our investor relations website at www.kewaunee.com and on the SEC website at www.sec.gov. These forward-looking statements speak only as of the date of this document. The Company assumes no obligation, and expressly disclaims any obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise.
Contact: | Donald T. Gardner III |
View original content to download multimedia:https://www.prnewswire.com/news-releases/kewaunee-scientific-to-report-results-for-first-quarter-fiscal-year-2025-302233395.html
SOURCE Kewaunee Scientific Corporation
FAQ
When will Kewaunee Scientific (KEQU) release its Q1 FY2025 financial results?
What products does Kewaunee Scientific (KEQU) manufacture?
Where are Kewaunee Scientific's (KEQU) manufacturing facilities located?
In which countries does Kewaunee Scientific (KEQU) have sales offices?
